Hindustan Bio Sciences (BOM:532041) ROCE %: -14.69% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532041 Hindustan Bio Sciences Ltd BOM:532041
51 GF Score
Price ₹7.20
GF Value ₹6.11
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Hindustan Bio Sciences ROCE %?

Hindustan Bio Sciences BOM:532041 +2.27% 51 ROCE % is -14.69% as of Mar. 2026. GuruFocus rates BOM:532041 with a GF Score™ of 51/100 and a GF Value™ of ₹6.11 (Modestly Overvalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hindustan Bio Sciences's annualized ROCE % for the quarter that ended in Mar. 2026 was -14.69%.

Hindustan Bio Sciences  (BOM:532041) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hindustan Bio Sciences ROCE % Related Terms

Hindustan Bio Sciences ROCE % Historical Data

* Premium members only.

The historical data trend for Hindustan Bio Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hindustan Bio Sciences ROCE % Chart

Hindustan Bio Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.26 -2.98 2.04 2.94 -2.37

Hindustan Bio Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.72 1.70 -6.72 9.49 -14.69
BOM:532041
51GF Score
Hindustan Bio Sciences Ltd BOM:532041
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hindustan Bio Sciences ROCE % Calculation

Hindustan Bio Sciences's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=-0.782/( ( (34.237 - 0.136) + (31.954 - 0.199) )/ 2 )
=-0.782/( (34.101+31.755)/ 2 )
=-0.782/32.928
=-2.37 %

Hindustan Bio Sciences's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-4.664/( ( (0 - 0) + (31.954 - 0.199) )/ 1 )
=-4.664/( ( 0 + 31.755 )/ 1 )
=-4.664/31.755
=-14.69 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -14.69% mean?
Hindustan Bio Sciences (BOM:532041) has a ROCE % of -14.69% as of Mar. 2026.
Is Hindustan Bio Sciences' ROCE % too high?
Hindustan Bio Sciences' current ROCE % is -14.69%. Overall, Hindustan Bio Sciences has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hindustan Bio Sciences' ROCE % compare to ZTS?
Hindustan Bio Sciences' ROCE % of -14.69% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hindustan Bio Sciences's current ROCE % is -14.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hindustan Bio Sciences stock overvalued right now?
Based on GuruFocus' analysis, Hindustan Bio Sciences (BOM:532041) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹6.11, compared to a current price of ₹7.20 — trading 17.8% above its estimated fair value. The current ROCE % is -14.69%. Hindustan Bio Sciences' overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Hindustan Bio Sciences (BOM:532041), the current ROCE % is -14.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hindustan Bio Sciences (BOM:532041) Overvalued in 2026?

Based on GuruFocus' analysis, Hindustan Bio Sciences stock appears to be overvalued. The current stock price of ₹7.20 is trading 17.8% above its estimated GF Value™ of ₹6.11. GuruFocus considers Hindustan Bio Sciences to be Modestly Overvalued.

Key valuation signals for BOM:532041:

  • ROCE %: -14.69%
  • GF Value™: ₹6.11 vs. price of ₹7.20 (17.8% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the BOM:532041 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hindustan Bio Sciences Business Description

Address Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an Indian pharmaceutical company, engaged in the manufacturing and sale of pharmaceutical products. The company manufactures and markets drugs and medicines in tablets, capsules, drops, externels, and syrup forms. Geographically, all of its revenue is generated through the export of its products to international markets.
51GF Score

Get the complete analysis for BOM:532041

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.20
Price
₹6.11
GF Value